SUPERNUS PHARMACEUTICA
36.57
29-11月-24 13:45:00
15 分の遅延
株式
-0.42
-1.14%
本日の幅
36.15 - 37.05
ISIN
N/A
ソース
NASDAQ
-
Busy Philipps Shines Spotlight on ADHD in Women and Shares her Qelbree Story
01 5 2024 08:00:32 提供 Nasdaq GlobeNewswire
-
24 4 2024 16:05:53 提供 Nasdaq GlobeNewswire
-
Supernus Provides Regulatory Update for SPN-830
08 4 2024 08:00:16 提供 Nasdaq GlobeNewswire
-
Supernus to Participate in Two Upcoming Investor Conferences
06 3 2024 16:30:50 提供 Nasdaq GlobeNewswire
-
Supernus to Participate in the TD Cowen 44th Annual Healthcare Conference
28 2 2024 16:30:04 提供 Nasdaq GlobeNewswire
-
Supernus Announces Fourth Quarter and Full Year 2023 Financial Results
27 2 2024 16:05:33 提供 Nasdaq GlobeNewswire
-
13 2 2024 16:05:20 提供 Nasdaq GlobeNewswire
-
Supernus Wins Infringement and Validity Case on Trokendi XR® against Torrent
05 2 2024 08:30:39 提供 Nasdaq GlobeNewswire
-
Supernus Announces Third Quarter 2023 Financial Results
08 11 2023 16:05:44 提供 Nasdaq GlobeNewswire
-
Supernus to Participate in the Jefferies London Healthcare Conference
07 11 2023 16:30:42 提供 Nasdaq GlobeNewswire
-
Supernus Announces SPN-830 Apomorphine Infusion Device NDA Accepted for Review by FDA
02 11 2023 07:00:05 提供 Nasdaq GlobeNewswire
-
25 10 2023 16:15:32 提供 Nasdaq GlobeNewswire
-
16 10 2023 17:34:21 提供 Nasdaq GlobeNewswire
-
Supernus Resubmits NDA for SPN-830 Apomorphine Infusion Device
09 10 2023 16:45:19 提供 Nasdaq GlobeNewswire
-
27 9 2023 16:15:50 提供 Nasdaq GlobeNewswire
-
Supernus Announces New Qelbree® Data Showing Improvement in ADHD Symptoms
09 9 2023 20:00:30 提供 Nasdaq GlobeNewswire
-
Supernus to Participate in the Wells Fargo Healthcare Conference
31 8 2023 17:30:19 提供 Nasdaq GlobeNewswire
-
Bethany L. Sensenig Joins Supernus’ Board of Directors
21 8 2023 09:00:54 提供 Nasdaq GlobeNewswire
-
Supernus Announces Second Quarter 2023 Financial Results
08 8 2023 16:17:24 提供 Nasdaq GlobeNewswire
-
Supernus to Participate in the Jefferies Healthcare Conference
31 5 2023 16:15:48 提供 Nasdaq GlobeNewswire